Literature DB >> 31926220

Dupilumab for the treatment of dyshidrotic eczema in 15 consecutive patients.

Reid A Waldman1, Madeline E DeWane1, Brett Sloan2, Jane M Grant-Kels1, Jun Lu3.   

Abstract

Entities:  

Year:  2020        PMID： 31926220     DOI： 10.1016/j.jaad.2019.12.053

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  2 in total

1.  Pipeline Perspectives and Therapy Updates.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2020-11-01

2.  Three cases of non-atopic hyperkeratotic hand eczema treated with dupilumab.

Authors:  Laura Loman; Gilles F H Diercks; Marie L A Schuttelaar
Journal:  Contact Dermatitis       Date:  2020-10-01       Impact factor: 6.600
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.